Bio-Rad Laboratories, Inc. Class A Common Stock vs ON Holding AG — how do they compare? Bio-Rad Laboratories, Inc. Class A Common Stock trades at $356.44 (market cap $9.43B), while ON Holding AG trades at $31.21 (market cap $10.33B). The key difference: Bio-Rad Laboratories, Inc. Class A Common Stock and ON Holding AG are close in size by market cap, and Bio-Rad Laboratories, Inc. Class A Common Stock is trading nearer its 52-week high, ON Holding AG nearer its low. Which is the better fit depends on your goals.
| BIO | ONON | |
|---|---|---|
Market Cap | $9.43B | $10.33B |
Sector | Health | Technology |
52-Week High | $356.25 | $50.63 |
52-Week Low | $241.71 | $30.91 |
Enterprise Value | $9.18B | $9.47B |
Trailing returns across standard periods
Latest headlines on both assets
Bio-Rad Laboratories, headquartered in Hercules, California, develops, manufactures, and markets products and solutions for the clinical diagnostics and life sciences markets. In diagnostics (53% of sales), Bio-Rad manufactures, sells, and supports test systems and specialized quality controls for clinical laboratories. In life sciences (47% of sales), the firm develops and manufactures a range of instruments and reagents used in research, biopharmaceutical production, and food testing. The company is geographically diverse, with major markets in the Americas (42% of 2021 sales), Europe and Africa (33%), and Asia-Pacific (25%). Bio-Rad owns 37% of Sartorius AG, a laboratory and biopharmaceutical supplier.
Read more on BIO →ON Holding AG is a Swiss sports company primarily known for its high-performance running shoes, apparel, and accessories under the 'On' brand. The company emphasizes a blend of high-end design, proprietary cloud technology (like CloudTec cushioning), and sustainability in its products. On has rapidly gained market share globally, appealing to both competitive athletes and general consumers in the performance and lifestyle footwear segments.
Read more on ONON →